British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
- PMID: 29449949
- PMCID: PMC5663249
- DOI: 10.1136/bmjresp-2017-000242
British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
Abstract
The full guideline for the management of non-tuberculous mycobacterial pulmonary disease is published in Thorax. The following is a summary of the recommendations and good practice points. The sections referred to in the summary refer to the full guideline.
Keywords: atypical mycobacterial infection; opportunist lung infections.
Conflict of interest statement
Competing interests: JB has received honorarium funding from AZ. TC has received funding from Chiesi. AF has received funding from GSK. ARF has received funding from Insmed. CSH has received funding from Aradigm, Chiesi, Gilead, Insmed, Raptor, Teva, Vertex and Zambon. ML has received funding from Insmed.
Figures
References
-
- Haworth CS. BTS Guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax 2017. - PubMed
-
- Haworth CS, Floto RA. Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax 2017. - PubMed
-
- Griffith DE, Aksamit T. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory & Critical Care Medicine. Am J Respir Crit Care Med 2007;175:367–416. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources